机读格式显示(MARC)
- 000 04085cam a2200349 i 4500
- 008 220713s2023 enka b 001 0 eng d
- 020 __ |a 9781032351865 |q hardback
- 020 __ |a 9781032351872 |q paperback
- 020 __ |z 9781003325741 |q electronic book
- 040 __ |a DLC |b eng |e rda |c DLC
- 050 00 |a K3943 |b .G8545 2023
- 082 00 |a 343.08/7 |2 23/eng/20221201
- 099 __ |a CAL 022023068969
- 100 1_ |a Guida, Alessandra, |e author.
- 245 10 |a Biosafety measures, technology risks and the World Trade Organization : |b thriving and surviving in the age of biotech / |c Alessandra Guida.
- 260 __ |a Abingdon, Oxon ; |a New York, NY : |b Routledge, |c 2023.
- 300 __ |a xxxv, 317 pages : |b illustrations ; |c 25 cm
- 336 __ |a text |b txt |2 rdacontent
- 337 __ |a unmediated |b n |2 rdamedia
- 338 __ |a volume |b nc |2 rdacarrier
- 500 __ |a Based on author's thesis (doctoral - Macquarie Law School, 2021).
- 504 __ |a Includes bibliographical references and index.
- 505 0_ |a International trade in biotechnology and protection of biosafety : an uneasy combination -- Normative, judicial and epistemic challenges for the WTO : free trade and biosafety -- Proportionality analysis to address WTO normative and judicial challenges in the context of biotechnology -- The precautionary principle to address WTO epistemic challenges in the context of biotechnology -- Introduction to and key reasons for a critical analysis of WTO biotechnology legal disputes -- Allocation of the burden of proof to establish a prima facie case and standard of review to examine biotechnology matters : preliminary issues in the WTO jurisprudence on biotechnology -- Adopting precautionary measures on biosafety in contexts of sufficient scientific evidence -- Adopting precautionary measures on biosafety in contexts of insufficient scientific evidence -- Conclusion.
- 520 __ |a "This book examines the work of the World Trade Organization (WTO), with a focus on the capacity of its judiciary to strike a reasoned balance between free trade in biotechnology and biosafety as to promote the 2030 Agenda for Sustainable Development and its Sustainable Development Goals. By adopting an innovative interpretation of the precautionary principle and proportionality analysis, the work offers normative suggestions to develop what the author terms "a constructive bridge of knowledge" between decision-makers, scientists, social experts, and expert witnesses, which can support a judicial balance by design, rather than by chance. Biotechnology is sometimes regarded as a panacea for modern-day challenges, such as feeding a growing world population and counteracting climate-change problems, and a means of offering significant economic opportunities. However, biotechnology can present uncertain, though serious, risks to human health and the environment (i.e., biosafety). Trading biotech products magnifies these risks and benefits globally. This book explores the topical, though still underexplored, question of how to find a point of equilibrium between the revolutionary advancement offered by technology and the need to safeguard biosafety from uncertain, though potentially irreversible, technology risks. It offers a thorough analysis of normative, judicial, and epistemic issues hindering a reasoned balance between trade and non-trade interests under the WTO. The work offers practical relevance for the resolution of legal disputes in contexts of uncertainty, as well as innovative theoretical contributions. It will be a valuable resource for policy-makers working on precautionary governance and management, scholars in the areas of trade law, human rights law, and environmental law, law students and practitioners, as well as NGOs working in the field of new technologies, biosafety, sustainability and food safety"-- |c Provided by publisher.
- 650 _0 |a Foreign trade regulation |x Environmental aspects.
- 650 _0 |a Biotechnology |x Safety regulations.